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Nanoparticle quantum dots (QDs) are ideal materials for multiplexed biomarker detection, localization, and 
quantification. Both direct and indirect methods are available for QD-based immunohistofluorescence (QD-IHF) 
staining; the direct method, however, has been considered laborious and costly. In this study, we optimized 
and compared the indirect QD-IHF single staining procedure using QD-secondary antibody conjugates and 
QD-streptavidin conjugates. Problems associated with sequential multiplex staining were identified quantitatively. 
A method using a QD cocktail solution was developed allowing simultaneous staining with three antibodies 
against E-cadherin, epidermal growth factor receptor and β-catenin in formalin-fixed and paraffin-embedded 
(FFPE) tissues. The expression of each biomarker was quantified by using the cocktail and the sequential 
methods. Comparison of the two methods demonstrated that the cocktail method provided more consistent 
and stable QD signals for each multiplexed biomarker than the sequential method, and provides a convenient 
tool for multiplexing biomarkers in both research and clinical applications. 
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In recent years, nanotechnology has developed rapidly 
and been used in molecular detection, imaging, 
diagnostics, and therapeutics in the cancer field [1, 2]. 
Quantum dots (QDs) are nanoscale particles made 
from inorganic semiconductors that can produce 
different fluorescence signals depending on their size 
and components. Compared with organic dyes, QDs 
have superior signal brightness and photostability, 
relatively long excited-state lifetime, and optimized 
signal-to-background ratios [3]. QDs can be covalently 
linked to biological molecules such as peptides, 
proteins, and nucleic acids, as well as streptavidin 
[4, 5]. Due to their long excitation time and narrow 
emission spectra, QDs can be excited simultaneously 
through one appropriate excitation source. Together 
these properties render QDs ideal for multiplexed 
biological imaging and they have been used for both  
molecular and cellular labeling [3–7].  
Many researchers reported that QDs can immuno- 
stain more than three biomarkers in formalin-fixed 
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paraffin-embedded (FFPE) tissues using QD-based 
immunohistofluorescence (QD-IHF) [8–11]. To date, 
several different staining procedures have been utilized, 
including direct and indirect staining, such as QDs 
linked to primary antibodies and QDs linked to 
secondary antibodies or streptavidin, respectively [9, 
10, 12, 13]. Although the direct staining method (QDs 
linked directly to a primary antibody) is straight- 
forward, the affinity of some primary antibodies may 
be reduced during the QD conjugation process. The 
conformation and function of the primary antibody 
may be changed and its binding properties are likely 
altered by covalent modifications at either –NH2 or 
–COOH sites [9, 14]. Furthermore, the reagent costs 
are considerable because each conjugation reaction 
requires up to 300 μg of antibody (Invitrogen protocol) 
and the yield of QD-antibody conjugates is usually 
low. Since each primary antibody is covalently 
conjugated to just one type of QD, changing the 
antibody for a particular QD probe is not possible 
once the conjugation is completed. Many researchers 
have abandoned the direct staining method since these 
problems can be avoided by indirect QD staining  
methods.  
The main advantages of indirect QD staining are 
its flexibility, lower costs, and the reduced constraints 
on primary antibodies. Although many studies have 
described detailed protocols for tissue specimen 
preparation, multicolor QD staining, and image 
processing [8, 9, 15], these have not provided  
detailed discussion or quantitative analysis of the 
optimization of their multiplexed biomarker staining 
procedures. In this study, we compared multiple QD 
staining in a sequential order with that in a 
simultaneous combination while using different 
methods—QD-secondary antibody conjugates and 
QD-streptavidin conjugates. QD staining of three 
biomarkers, epidermal growth factor receptor (EGFR), 
E-cadherin (E-cad), and β-catenin (β-cat), was examined 
and quantitatively evaluated with these staining  
methods for each of the tested biomarkers.  
1. Experimental 
Using an institutional review board-approved consent 
for tissue acquisition, tissue samples for this study 
were obtained from surgical specimens from patients 
who were diagnosed at Emory University Hospital 
with squamous cell carcinoma of the head and neck 
(SCCHN). After a routine process to generate FFPE 
samples, the blocks were sectioned to 4 μm each and 
mounted on coated slides. Each sample was analyzed 
by hematoxylin and eosin (H&E) staining. Before 
QD-IHF staining, we confirmed that the primary 
antibodies were suitable for immunohistochemistry 
(IHC) and also selected FFPE samples which were 
strongly positive for staining of the primary antibodies 
as positive control slides.  
We selected mouse anti-human E-cad, rabbit anti- 
human EGFR, and goat anti-human β-cat as the 
primary antibodies, since these antigens are strongly 
expressed in SCCHN tissues. We found previously 
that expression and localization of E-cad and EGFR 
correlated with metastasis and poor prognosis [16]. 
QD-secondary antibody conjugates (QD-2nd Ab) and 
QD-streptavidin conjugates (QD-streptavidin) were 
selected as follows: Qdots® 565 goat F(ab´)2 anti-mouse 
immunoglobulin G (IgG) conjugate, Qdots® 605 goat 
F(ab´)2 anti-rabbit IgG conjugate, Qdots® 655 rabbit 
F(ab´)2 anti-goat IgG conjugate, and Qdots® streptavidin 
conjugate (565, 605, 655). 
The QD-IHF procedure with single QD-2nd Ab 
was carried out as follows (shown in the cartoon in 
Fig. 1(a)). After deparaffinization and rehydration, 
antigen retrieval was performed by heating with citric 
acid (10 mmol/L, pH 6.0) in a microwave to 95 °C for 
10 min. The tissue slides were blocked with 5% normal 
goat serum (Dako) for 10 min before the primary 
antibody incubation (E-cad 1:2000 dilution, EGFR 
1:150 dilution, or β-cat 1:2000 dilution) for 1 h at  
37 °C. Following three washes with phosphate-buffered 
saline (PBS) (5 min each), the slides were incubated 
with QD [QD565 goat F(ab´)2 anti-mouse IgG con- 
jugate, QD605 goat F(ab´)2 anti-rabbit IgG conjugate, 
or QD655 rabbit F(ab´)2 anti-goat IgG conjugate, 
accordingly] in 6% bovine serum albumin (BSA) for 
1 h at 37 °C. After washing three times with PBS, the 
nuclei were counterstained with 4´,6-diamidino-2- 
phenylindole (DAPI) (Invitrogen, Carlsbad, CA, USA). 
The slides were mounted with CytosealTM 60 mounting  
medium (Richard-Allan Scientific, MI). 
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For QD-IHF staining with QD-streptavidin (shown 
in the cartoon in Fig. 1(b)), slides were prepared as 
above. After the primary antibody incubation, slides 
were incubated with biotinylated 2nd Ab for 20 min 
at room temperature (RT), and washed three times 
with PBS (5 min each). Slides were incubated with 
QD565-, QD605-, or QD655-streptavidin (1:100) in  
6% BSA for 1 h at 37 °C and washed three times with 
PBS (5 min each). After nuclei counterstaining and 
mounting, the slides were kept in the dark at 4 °C for 
visualizing and quantifying. Mouse, rabbit or goat  
IgG was used as a negative control.  
For sequential QD-IHF staining with QD-streptavidin, 
after the first primary antibody E-cad incubation 
(1:2000 dilution), the slides were incubated with the 
biotinylated 2nd Ab for 20 min at room temperature 
and washed three times with PBS (5 min each). Slides 
were then incubated with QD565-streptavidin (1:100) 
in 6% BSA for 1 h at 37 °C and washed three times with 
PBS (5 min each). After staining the first biomarker 
with QDs, the staining procedure was repeated from 
the blocking step, except the primary antibody and 
 
Figure 1 Comparison of single QD-IHF staining using QD-2nd Ab with QD-streptavidin: (a) cartoon showing single QD-IHF staining
with QD-2nd Ab conjugates; (b) cartoon showing single QD-IHF staining with QD-streptavidin conjugates; (c) RGB image of E-cad
QD-IHF staining with QD565-2nd Ab; (d) RGB image of E-cad QD-IHF staining with QD565-streptavidin; (e) signal intensity comparison
between QD-2nd Ab and QD-streptavidin 
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QD conjugate were replaced with second biomarker 
EGFR (1:150) and QD605-streptavidin (1:100), 
respectively. Then the slides were mounted after 
nuclear counterstaining. For QD signal comparison, 
we also switched the staining sequence from EGFR 
with QD565-streptavidin staining as the first step to 
E-cad with QD605-streptavidin staining as the second. 
Mouse and rabbit IgG were used as a negative control. 
For the cocktail staining method, we chose primary 
antibodies of distinct species origins, including mouse 
anti-human E-cad, rabbit anti-human EGFR, and goat 
anti-human β-cat. Therefore, for QD-2nd Abs, we 
selected QD565 goat F(ab´)2 anti-mouse IgG, QD605 
goat F(ab´)2 anti-rabbit IgG, and QD655 rabbit F(ab´)2 
anti-goat IgG, respectively. After preparation steps, 
the slides were incubated with the three primary 
antibodies against E-cad (1:2000), EGFR (1:150), and 
β-cat (1:2000) simultaneously for 1 h at 37 °C. After 
washing three times with PBS, the three QD-2nd Abs 
in a cocktail solution at 1:100 dilution were added to 
the slides with further incubation for 1 h at 37 °C. 
Slides were washed three times in PBS, counterstained, 
mounted, and stored as described above. For the 
sequential method (shown in the cartoon in Fig. 4(a)(ii)), 
the additional biomarker β-cat was stained by 
incubation with QD655-streptavidin following staining 
for E-cad with QD565-streptavidin and EGFR with 
QD605-streptavidin as above. The IgG with the same 
host species as the 2nd Ab was used as a negative  
control. 
An Olympus microscope IX71 with CRi Nuance 
spectral imaging and quantifying system (CRi Inc., 
Woburn, MA, USA) was used to observe and quantify 
the QD signals. All cubed image files were collected 
from the FFPE tissue slides at 10-nm wavelength 
intervals from 500 to 800 nm with an auto exposure time 
at 200×  magnification. Taking the cube with a long 
wavelength bandpass filter allowed transmission of 
all emission wavelengths above 450 nm. Both mixed 
and separated QD images were established after 
determining the QD spectral library and unmixing 
the cube. Background and auto-fluorescence were 
removed for accurate quantification of each QD 
signal. For comparison of the QD signals, we defined 
the measurement threshold as the same in each case. 
An arbitrary unit (a.u.) was defined as the average 
fluorescence signal intensity per exposure time (ms), 
in which the exposure time was optimized so that the 
differences in fluorescence intensity among QDs 
were minimized and the same exposure time could 
be used for all QDs. These values were obtained 
directly from the Nuance software. Ten randomly 
selected fields in each sample slide were used for 
quantification. Data are presented as a mean of ten  
readings with the standard deviation (S. D.). 
2. Results and discussion 
We used the quantification results to evaluate the 
working conditions. It was found that (1) the same 
antigen retrieval method as used in IHC also 
performed well in QD-IHF staining of FFPE samples; 
(2) the optimized working conditions for primary 
antibodies in IHC also worked well for QD-IHF; (3) 
incubation of the QD-conjugates from Invitrogen at 
10–20 nmol/L and 37 °C for 1 h was sufficient to reach 
a balance of the maximum staining effect with 
minimized non-specific binding. Non-specific binding 
increased when increasing either the concentration or 
the incubation time of the QD-conjugates, suggesting 
that 10–20 nmol/L of QD-conjugate may be a saturating 
level for staining. There was almost no significant 
difference in the intensity of QD signal when the 
concentration of QD-conjugates reached 20 nmol/L, 
but the non-specific binding increased directly (data 
not shown), suggesting that the QD binding was 
saturated at 20 nmol/L; (4) multiple PBS washing up 
to three times did not reduce the QD signal intensity. 
The effects of other washing buffers, such as PBS 
with Tween-20 (PBS-T) or Tris-buffered saline with 
Tween-20 (TBS-T), were similar to that of PBS. The 
antigen retrieval method, dilution, and incubation 
condition of the antibody are the main factors that 
affect the results of immunostaining FFPE tissues. 
Most researchers use the same retrieval method and 
incubation conditions for primary antibodies when 
conducting IHC and IHF stained with QDs. There are 
several issues that we have to address before 
immunostaining with QD-bioconjugates: (1) do the 
optimized working conditions for IHC work well for 
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QD-IHF? (2) how can we control the dilution ratio for 
QD-conjugates and the incubation conditions to obtain 
a balance between an optimal signal and minimized 
non-specific binding? (3) how can we optimize the 
QD-IHF staining procedure, especially in multiple 
staining? These potential problems have been addressed  
using the quantification data in our studies. 
Figure 1 shows that the signal when staining with 
QD-2nd Ab was lower than that with QD-streptavidin 
(Figs. 1(c), 1(d)). The quantification results also 
showed that the average intensity from QD- 
streptavidin staining was 1.36–1.73-fold greater than 
that from QD-2nd Ab staining (Fig. 1(e)). The staining  
with QD-streptavidin had some amplification effect.  
For multiplex QD staining, the sequential staining 
method is used by most researchers [8, 12]. To 
investigate whether the intensity of the QD signal 
after the first step changes or not after the subsequent 
biomarker staining and many washing steps, we 
initially tested sequential QD-IHF staining of E-cad 
with QD565-streptavidin followed by EGFR with 
QD605-streptavidin, and then altered this sequence. 
The staining signals from the two experiments were 
quantified and compared. It was found that the QD 
intensity of E-cad staining when stained first was 
0.104 ± 0.050 compared with 0.534 ± 0.132 when stained 
second (Fig. 2(a)). Similarly, the intensity of EGFR 
staining when stained first was 0.189 ± 0.104 compared 
with 0.565 ± 0.098 when stained second (Fig. 2(b)). 
This result indicated that the intensity of the first QD 
signal after the initial biomarker staining was reduced  
following the second blocking and washing steps.  
In order to achieve the best staining of each 
biomarker using the QD-IHF sequential method, the 
selection of QDs may be considered. Our study has 
demonstrated that the intensity of QDs from 
Invitrogen at the same concentration was different 
and varied in the order QD655 > QD605 > QD565 
(Fig. 3). In theory, the QD with highest intensity is 
recommended to be used in the first step to offset the 
decreasing signal when staining with QD-IHF in a  
sequential manner. 
In order to avoid the decrease in signal observed 
with sequential staining, we applied three mixed 
primary antibodies with distinct species origins to the 
tissue slides and then incubated the relevant QD-2nd 
 
Figure 2 Comparison of the first signal with the second signal in a sequential QD-IHF staining. (a) E-cad with QD565-streptavidin as
the first biomarker and EGFR with QD605-streptavidin as the second. (b) EGFR with QD605-streptavidin as the first biomarker and
E-cad with QD565-streptavidin as the second. (i) unmixed first signal; (ii) unmixed second signal; (iii) quantification comparison
between these two biomarkers 
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Abs in a cocktail solution in order to make the IHF 
staining efficient and simple [shown in the cartoon in 
Fig. 4(a)(i)]. The level of each QD signal obtained from 
the cocktail method was quantified and compared to  
that obtained with the sequential method. It was 
found that all of the QD signals obtained by the 
QD-IHF cocktail method were consistent (Fig. 4(b)). 
The intensities of E-cad, EGFR, and β-cat were 0.318 ± 
0.015, 0.309 ± 0.034, and 0.362 ± 0.036, respectively 
(Fig. 4(d)). In contrast, the signals from the sequential 
staining method were not consistent (Fig. 4(c)). 
Intensities of the second and the third signals were, 
respectively, 1.57–2.20- and 5.80–8.24-fold higher than  
the first signal (Fig. 4(d)). 
Because the properties of nanocrystals are highly 
dependent on the surface environment, whether the 
stability with respect to the optical emission peak 
maximum and color purity of the QDs in such a 
cocktail solution may be changed is always a 
consideration. As recommended by the QD 
manufacturer, Invitrogen Cooperation, we diluted 
the three QDs with 6% BSA in PBS solution, and 
tested the signal intensity of the QDs either singly or 
in a cocktail solution using a spectrofluorimeter 
[QuantaMaster™ UV VIS, Photon Technology 
International (PTI)]. Our study confirmed that the 
QD signals in PBS appeared at the expected 
wavelength with reasonable sensitivity (Fig. 3). 
Furthermore, the fluorescence intensity of each QD 
was not altered in the cocktail solution when compared  
to the single QD solution (Fig. 3).  
One of the drawbacks of the cocktail method is 
that it can be challenging to find more than four 
primary antibodies with distinct species origins for 
simultaneous IHF staining, which limits the use of 
this method to not more than four biomarkers. In the 
case of multiplexing more than four biomarkers, the 
cocktail plus the sequential method may be applied. 
3. Conclusions 
We have demonstrated that the signal intensities 
using the QD-streptavidin-based staining method 
were higher than those with QD-2nd Ab. QD staining 
signals using the cocktail method were more 
consistent and stable than those obtained using the 
sequential method. In order to achieve the optimal 
signal for each biomarker in a QD-IHF multiplexed 
staining procedure, the staining method selection  
and QD intensity should be considered.  
 
Figure 3 Comparison of QD emission intensity in single QD and cocktail PBS solutions. Fluorescence intensity of each of the three
QDs was detected by QuantaMaster™ UV VIS, (Photon Technology International, Birmingham, NJ) 
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